This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Maar Dora Francesco Carelli, University of Milan (12 Dec 2019)
Anastrozole reduces breast cancer rates for ... Queen Mary University of London-led research finds Anastrozole ... (10 Dec 2019)
Taking fish oil tablets for four weeks ... Fish oil supplements can significantly improve ‘night vision’, ... (12 Dec 2019)
Give a Gift this Christmas which gives back The story of medicine is the story of civilization, from an ... (12 Dec 2019)
Elderly people should aim to keep up step ... Just two weeks of inactivity increases body fat and harms ... (12 Dec 2019)
×

Warning

JUser: :_load: Unable to load user with ID: 5232

Displaying items by tag: heart failure

Implantable cardioverter-defibrillator (ICD) use is associated with reduced short- and long-term mortality in patients with heart failure, according to late breaking research presented at ESC Congress 2019 together with the World Congress of Cardiology1 and published in Circulation.

Published in Medical News

Beta-blockers remain effective for preventing death in heart failure with reduced ejection fraction (HFrEF) and sinus rhythm, even in patients with moderate or moderately-severe kidney dysfunction, according to late breaking research presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology.

Published in Medical News

Elderly patients with heart failure who see a pharmacist once a week are more likely to take their tablets and be active in daily life, according to late breaking results from the PHARM-CHF randomised controlled trial presented today at Heart Failure 2019, a scientific congress of the European Society of Cardiology (ESC).1

Published in Medical News
Saturday, 25 May 2019 14:41

A gut check for heart failure patients

Heart failure patients who consume more dietary fibre tend to have healthier gut bacteria, which is associated with reduced risk of death or need of a heart transplant. The fibre study was presented today at Heart Failure 2019, a scientific congress of the European Society of Cardiology (ESC).1

Published in Medical News

Heart Failure with Preserved Ejection Fraction (HFpEF) especially affects women and the elderly. The authors review the importance of the heterogeneity of this condition and its implications on therapeutic approaches. Although there are no sex-specific recommendations regarding the evaluation and management of HFpEF in women compared with men, women are more likely to have the HFpEF phenotype than HFrEF.

Published in Medical News

Researchers at the University of Arizona have discovered that metformin, a drug commonly used to treat type 2 diabetes, might also be used to treat heart failure with preserved ejection fraction (HFpEF), a condition that is predicted to affect over 8% of people ages 65 or older by the year 2020. The study, which was published in the Journal of General Physiology, shows that metformin relaxes a key heart muscle protein called titin, allowing the heart to properly fill with blood before pumping it around the body.

Published in Medical News
Page 1 of 3

Jamesco News

Has no content to show!

GSK

Vivian

TheSynapse Magazines

Latest news

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…